Company Filing History:
1 out of 164 
1 out of 38 
Years Active: 2014
Title: The Innovative Contributions of Nigel Ra Beeley
Introduction
Nigel Ra Beeley is a notable inventor based in Solana Beach, California. He has made significant contributions to the field of medical treatments, particularly through his innovative work with exendin and GLP-1 peptides. His research focuses on methods that can improve patient outcomes in various health conditions.
Latest Patents
Nigel Ra Beeley holds a patent for "Methods of treatment using exendin peptides or GLP-1 peptides." This patent outlines methods for increasing urine flow through the administration of effective amounts of GLP-1, exendin, or their agonists. Additionally, it describes methods for increasing urinary sodium excretion and decreasing urinary potassium concentration. These methods are particularly useful for treating conditions associated with toxic hypervolemia, such as renal failure, congestive heart failure, nephrotic syndrome, cirrhosis, pulmonary edema, and hypertension. The invention also includes methods for inducing an inotropic response, which can help alleviate conditions that benefit from increased cardiac contractility, such as congestive heart failure. Furthermore, pharmaceutical compositions for these methods are also disclosed.
Career Highlights
Throughout his career, Nigel has worked with prominent companies in the pharmaceutical industry, including Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed to his expertise in developing innovative medical treatments.
Collaborations
Nigel has collaborated with several professionals in his field, including Andrew A Young and Will Vine. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Nigel Ra Beeley's contributions to medical treatment innovations through his patent on exendin and GLP-1 peptides demonstrate his commitment to improving patient care. His work continues to influence the pharmaceutical industry and offers hope for better treatment options for various health conditions.